Abstract
Perthiolated β-cyclodextrin-based nanocapsules incorporating diaquo Gd(III)-complexes represent a promising new type of bioresponsive MRI contrast agent, showing a pronounced relaxivity change upon degradation in a reducing environment.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Chelating Agents / chemistry*
-
Contrast Media / chemistry*
-
Gadolinium / chemistry*
-
Hydrogen-Ion Concentration
-
Magnetic Resonance Imaging
-
Nanocapsules / chemistry*
-
beta-Cyclodextrins / chemistry*
Substances
-
Chelating Agents
-
Contrast Media
-
Nanocapsules
-
beta-Cyclodextrins
-
Gadolinium
-
betadex